COVID-19-accelerated disease progression in two patients with amyotrophic lateral sclerosis
- PMID: 34131925
- PMCID: PMC8441768
- DOI: 10.1002/mus.27351
COVID-19-accelerated disease progression in two patients with amyotrophic lateral sclerosis
Conflict of interest statement
R.B. has received research support from ALS Association, MediciNova, and Orion, and served as a paid consultant for Alexion, ALS Association, Amylyx, Biogen, Brainstorm Cell, Mallinkrodt, MT Pharma, New Biotic, Orphazyme, and Woolsey Pharma. X.L. declares no conflicts of interest.
Figures

References
-
- Brooks BR, Miller RG, Swash M. World Federation of Neurology Research Group on Motor Neuron Diseases El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293‐299. - PubMed
-
- Esselin F, De La Cruz E, Pageot N, Juntas‐Moralès R, Alphandéry S, Camu W. Increased worsening of amyotrophic lateral sclerosis patients during Covid‐19‐related lockdown in France. Amyotroph Lateral Scler Frontotemporal Degener. 2021;1‐3. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical